Fenwick advised Melinta Therapeutics on the deal. Melinta Therapeutics, a company providing innovative therapies for acute and life-threatening illnesses, announced its acquisition of the U.S. rights to...
Melinta Therapeutics’ Acquisition of U.S. Rights to TOPROL-XL from New American Therapeutics
Snowflake’s Acquisition of Streamlit
Baker McKenzie advised Snowflake on the deal while Fenwick represented Streamlit. Snowflake executed the acquisition of Streamlit, a framework built to simplify and accelerate the creation of...
Metagenomi’s Collaboration with Moderna
Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal. Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...
Veracyte’s €260 Million Pending Acquisition of HalioDx
Fenwick & West LLP and Latham & Watkins LLP advised Veracyte on the deal, while Shearman & Sterling advised HalioDx and its shareholders. SVZ advised Amundi...